Literature DB >> 9989326

Recruitment for complementary/alternative medicine trials: who participates after breast cancer.

M A Richardson1, J Post-White, S E Singletary, B Justice.   

Abstract

BACKGROUND: Despite the popularity and widespread practice of complementary/alternative medicine (CAM), researchers may face problems accruing patients to randomized clinical trials, considered the gold standard of biomedical research. Strict exclusion criteria and barriers to participation may limit accrual. Inadequate numbers of subjects decrease the ability of studies to detect an effect that exists and generalize their findings. This article describes the recruitment experience of a CAM trial, details reasons for non-participation, and contrasts participants and non-participants on demographic, clinical, and treatment-related variables.
METHODS: Women who were Houston area residents and spoke English, had primary breast cancer (excluding Stage IV), and were 1 to 30 months posttreatment with no steroids, tamoxifen, substance abuse, psychiatric or heart disease, or immune deficiency were eligible. The enrollment process involved three contacts (i.e. introductory letter and brochure, telephone calls, and reminder post cards). Potential participants were told that the study would require blood samples (30 cc) to assess immune function; psychosocial measures to assess emotional well-being, quality-of-life, social support, and coping strategies; and possible assignment to six weekly support or imagery sessions. Factors influencing recruitment and reasons for non-participation were assessed by stratified analysis and multivariate logistic regression.
RESULTS: Of 158 eligible participants, 30% (N = 47) consented to participate. Primary reasons for non-participation included work/childcare (33.3%), transportation/travel (30.6%), and lack of interest (24.3%). Participants were more likely to be 40-54 years of age versus younger or older, divorced/separated, and able to pay some/all medical expenses. Divorced or separated women appeared to be more likely to participate, regardless of financial status.
CONCLUSIONS: Researchers must assess the impact of exclusion criteria on accrual and recognize the special needs of their target population. Although age, marital status, and pay status were the strongest predictors of participation, these factors are not amenable to intervention. Based on this study, researchers might boost accrual by providing interventions available during the day and evening to accommodate working women, child care services, transportation, or reimbursement for travel costs.

Entities:  

Mesh:

Year:  1998        PMID: 9989326     DOI: 10.1007/BF02884960

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  6 in total

1.  Research into complementary and alternative medicine: problems and potential.

Authors:  R L Nahin; S E Straus
Journal:  BMJ       Date:  2001-01-20

2.  Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study.

Authors:  Malaika N Woods; Kari Jo Harris; Matthew S Mayo; Delwyn Catley; Monica Scheibmeir; Jasjit S Ahluwalia
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

3.  Evaluation of conceptual framework for recruitment of African American patients with breast cancer.

Authors:  Sue P Heiney; Swann Arp Adams; Linda M Wells; Hiluv Johnson
Journal:  Oncol Nurs Forum       Date:  2010-05       Impact factor: 2.172

4.  Finding Canadian cancer clinical trials on the Internet: an exploratory evaluation of online resources.

Authors:  James E Till; Robert A Phillips; Alejandro R Jadad
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

5.  Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study.

Authors:  Jun J Mao; Tiffany Tan; Susan Q Li; Salimah H Meghani; Karen Glanz; Deborah Bruner
Journal:  BMC Complement Altern Med       Date:  2014-01-08       Impact factor: 3.659

6.  An analysis of sickness absence in chronically ill patients receiving complementary and alternative medicine: a longterm prospective intermittent study.

Authors:  Susanne Moebus; Nils Lehmann; Wolfgang Bödeker; Karl-Heinz Jöckel
Journal:  BMC Public Health       Date:  2006-02-12       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.